Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

11.15USD
1 Aug 2013
Price Change (% chg)

$0.23 (+2.11%)
Prev Close
$10.92
Open
$10.96
Day's High
$11.49
Day's Low
$10.92
Volume
5,261,517
Avg. Vol
3,075,148
52-wk High
$11.49
52-wk Low
$5.04

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions,... (more)

Overall

Beta: 1.23
Market Cap (Mil.): $14,732.09
Shares Outstanding (Mil.): 1,349.09
Dividend: --
Yield (%): --

Financials

  BSX.N Industry Sector
P/E (TTM): -- 66.39 37.76
EPS (TTM): -0.60 -- --
ROI: -5.42 4.99 18.76
ROE: -11.54 9.80 19.59
Search Stocks

UPDATE 3-Boston Scientific signals new growth, shares up 11 pct

* Revenue from stents, implantable defibrillators stabilizes (Adds analyst comments, company comments, financial details, updates stock price)

25 Jul 2013

REFILE-Boston Scientific reports second-quarter profit as revenue dips

July 25 - Boston Scientific Corp on Thursday reported a second-quarter profit, reversing a year-earlier loss, and said sales in its medical surgical device business had risen.

25 Jul 2013

RPT-INSIGHT-Apple controversy lays bare complex Irish tax web

* More than 40 percent of S&P 500 have subsidiaries in Ireland

15 Jul 2013

Fitch Affirms Boston Scientific's IDR at 'BBB-'; Outlook Stable

(The following statement was released by the rating agency) CHICAGO, July 12 (Fitch) Fitch Ratings has affirmed Boston Scientific Corp.'s (NYSE: BSX) Issuer Default Rating (IDR) at 'BBB-'. A full list of BSX's ratings follows at the end of this release. The rating action applies to approximately $4.25 billion of debt. The Rating Outlook is Stable. KEY RATING DRIVERS: --Fitch expects BSX will operate with relatively stable leverage (total debt/EBITDA) of 2.3 times (x) to 2.5x during the next

12 Jul 2013

Boston Sci to buy Bard electrophysiology unit for $275 mln

WASHINGTON, June 28 - Medical device maker Boston Scientific Corp said on Friday it would buy the electrophysiology (EP) business of C.R. Bard Inc for $275 million in cash, expanding its roster of products that help treat patients with an abnormal heartbeat.

28 Jun 2013

Boston Scientific says on path to growth

- Medical device maker Boston Scientific Corp reported better-than-expected first-quarter results on Thursday, which the company said will put it on the path to return to growth.

25 Apr 2013

UPDATE 2-Boston Scientific says on path to growth

April 25 - Medical device maker Boston Scientific Corp reported better-than-expected first-quarter results on Thursday, which the company said will put it on the path to return to growth.

25 Apr 2013

Boston Scientific posts loss on restructuring, lawsuits

- Medical device maker Boston Scientific Corp posted a first-quarter loss on Thursday as it took $578 million in charges for litigation and restructuring, including reducing its workforce.

25 Apr 2013

Boston Scientific posts first-quarter loss

April 25 - Medical device maker Boston Scientific Corp on Thursday posted a first-quarter loss due to $578 million in restructuring, litigation and other charges.

25 Apr 2013

Boston Scientific atrial fibrillation device proves safe -study

SAN FRANCISCO/CHICAGO, March 9 - A tiny upside down umbrella-shaped device implanted on the heart to prevent stroke in patients with a dangerous irregular heart rhythm known as atrial fibrillation appeared to be safe in a highly anticipated clinical trial, providing an alternative to clot-preventing blood thinners.

09 Mar 2013

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $93.77 +0.27
Medtronic, Inc. (MDT.N) $55.49 +0.25
Abbott Laboratories (ABT.N) $36.84 +0.21
St. Jude Medical, Inc. (STJ.N) $53.00 +0.61

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$58.00
Provider: Stock Traders Daily
$495.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks